Format

Send to

Choose Destination
Diagn Interv Imaging. 2015 Jun;96(6):647-54. doi: 10.1016/j.diii.2015.04.004. Epub 2015 May 16.

Interventional oncology for liver and lung metastases from colorectal cancer: The current state of the art.

Author information

1
Gustave-Roussy Cancer Campus, Institut Gustave-Roussy, 112, rue Édouard-Vaillant, 94805 Villejuif, France. Electronic address: debaere@igr.fr.
2
Gustave-Roussy Cancer Campus, Institut Gustave-Roussy, 112, rue Édouard-Vaillant, 94805 Villejuif, France.

Abstract

Interventional oncology is developing rapidly as a result of advances in imaging and medical devices. Although the treatments offered are recent and not yet fully validated in the guidelines, they allow non-invasive curative treatments to be offered to a growing number of patients. When it is used in a highly selected patients with less than three metastases under 2-3cm in size, percutaneous tumor ablation offers local efficacy similar to excision surgery with considerable sparing of the parenchyma, both for lung and liver metastases. Hepatic intra-arterial therapies (chemotherapy, radioembolization, and chemoembolization) are now "salvage" methods after chemotherapy has failed and are being assessed in earlier lines of treatment.

KEYWORDS:

Chemotherapy; Colorectal cancer; Image-guided surgery; Metastases; Radiofrequency

PMID:
25985998
DOI:
10.1016/j.diii.2015.04.004
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center